acarix News August 6, 2024 03 Apr 2023 Acarix accelerates US commercialization into 30 additional states Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced a strategic sales partnership with CompleMed, LLC, a nat... Continue reading
acarix News August 6, 2024 14 Mar 2023 Study published in Heart strengthens diagnostic value of Acarix CADScor System Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announced the release of a new study published in the March 2023 i... Continue reading
acarix News August 6, 2024 06 Mar 2023 Acarix presents at Redeye: Commercialization Seminar On March 7 at 10.30 CET Helen Ljungdahl Round, CEO of Acarix, presents the latest developments in the company at Redeye. Continue reading
acarix News August 6, 2024 03 Mar 2023 Acarix to showcase at the 2023 ACC congress Acarix, a leader in acoustic and AI-based cardiac diagnostics, will demonstrate the value of its CADScor System during the American Col... Continue reading
acarix News August 6, 2024 21 Feb 2023 Acarix receives breakthrough order from US Veterans Health Administration Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati... Continue reading
acarix News August 6, 2024 16 Feb 2023 Invitation to presentation of Acarix´s fourth quarter report Acarix will publish its fourth quarter results on Thursday 16 February 2023 at 08.00 am (CEST). A live webcast will be held at 11.00 (C... Continue reading
acarix News August 6, 2024 16 Feb 2023 Acarix AB (publ) publishes Year-End Report 2022 Strategic shift towards full commercial focus on the US market now in placeAs we sum up 2022, it becomes clear that Acarix has in a sho... Continue reading
acarix News August 6, 2024 14 Feb 2023 Acarix strengthens US Commercial Team Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the appointment of two additional members of the Acarix ... Continue reading
acarix News August 6, 2024 06 Feb 2023 Acarix is attending 2023 BIO CEO & Investor Conference Acarix, a leader in innovative acoustic and AI-based cardiac diagnostics, will be attending for the first time the 25th annual BIO CEO ... Continue reading
acarix News August 6, 2024 21 Dec 2022 Acarix CEO on the company’s US initiative for increased growth Acarix is in full swing with the launch of CADScor System, an acoustic and AI-based technology for the diagnosis of cardiovascular dise... Continue reading
acarix News August 6, 2024 18 Nov 2022 Helen Ljungdahl Round, CEO of Acarix Presents at Redeye Life Science Day 2022 On November 24th at 14.50 CET, Helen Ljungdahl Round, CEO of Acarix presented at Redeye Life Science Day 2022. The presentation showcas... Continue reading
acarix News August 6, 2024 09 Nov 2022 Article published: Improved pre-test likelihood estimation of coronary artery disease using phonocardiography Article published by PhD student, Bjarke Skogstad Larsen from Acarix: Improved pre-test likelihood estimation of coronary artery diseas... Continue reading